1-11 of 11
Keywords: NMDA antagonists
Sort by
Journal Article
Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis
Get access
M. Soledad Cepeda and others
Pain Medicine, Volume 13, Issue 4, April 2012, Pages 575–595, https://doi.org/10.1111/j.1526-4637.2012.01340.x
Published: 12 April 2012
.... Placebos Anticonvulsants Antidepressants NMDA Antagonists Opioids Post-Herpetic Neuralgia Reflex Sympathetic Dystrophy Risk Factors Neuropathy A high placebo response has been identified as one of the strongest factors that lead to failed clinical trials, even when the active treatment has been...
Journal Article
Analgesic Effect of Subanesthetic Intravenous Ketamine in Refractory Neuropathic Pain: A Case Report
Get access
Osama Elsewaisy and others
Pain Medicine, Volume 11, Issue 6, June 2010, Pages 946–950, https://doi.org/10.1111/j.1526-4637.2010.00863.x
Published: 02 June 2010
... in the management of refractory chronic neuropathic pain. We discuss chronic idiopathic axonal polyneuropathy, neuropathic pain mechanisms, and the use of ketamine in this report. Neuropathic Pain NMDA Antagonists Ketamine Chronic Idiopathic Axonal Polyneuropathy The effective management of refractory...
Journal Article
Intravenous Magnesium for Complex Regional Pain Syndrome Type 1 (CRPS 1) Patients: A Pilot Study
Get access
Susan Collins and others
Pain Medicine, Volume 10, Issue 5, July 2009, Pages 930–940, https://doi.org/10.1111/j.1526-4637.2009.00639.x
Published: 28 July 2009
... are encouraging and suggest that magnesium IV as a treatment in CRPS 1 should be further explored in a large size formal trial design. CRPS NMDA Antagonists Magnesium Complex Regional Pain Syndrome type 1 (CRPS 1) is a painful disorder of the extremities that may occur after trauma. CRPS 1 is characterized...
Journal Article
Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine
María Cecilia Scorza and others
International Journal of Neuropsychopharmacology, Volume 11, Issue 4, June 2008, Pages 519–532, https://doi.org/10.1017/S1461145708008432
Published: 01 June 2008
... activity NMDA antagonists prefrontal cortex Non-competitive NMDA receptor antagonists, such as phencyclidine or MK-801 induce a potent behavioural syndrome (hyperactivity, ataxia signs, stereotypies), as well as cognitive and sensory deficits in experimental animals that resemble human schizophrenia...
Journal Article
A Pilot Open-Label Study of the Efficacy of Subanesthetic Isomeric S(+)-Ketamine in Refractory CRPS Patients
Get access
Ralph-Thomas Kiefer and others
Pain Medicine, Volume 9, Issue 1, January 2008, Pages 44–54, https://doi.org/10.1111/j.1526-4637.2006.00223.x
Published: 23 July 2007
..., the disease may spread extraterritorially, which results in severe disability. A critical involvement of N-methyl-D-aspartate receptors (NMDARs) has been demonstrated both clinically and by animal experimentation. NMDA antagonists may be effective in many neuropathic pain states. In long-standing, generalized...
Journal Article
Topical Ketamine in the Treatment of Mucositis Pain
Get access
Neal E. Slatkin and Michelle Rhiner
Pain Medicine, Volume 4, Issue 3, September 2003, Pages 298–303, https://doi.org/10.1046/j.1526-4637.2003.03032.x
Published: 17 September 2003
..., and, potentially, other causes of inflammatory oral pain, are warranted. Ketamine Mucositis Radiation Therapy NMDA Antagonists Head and Neck Cancer Mucositis is a common complication of high-dose oropharyngeal radiation therapy in patients with head and neck cancer [1,2] . Patients with moderate-to-severe...
Chapter
Miscellaneous Pharmacology
Get access
Ramana K. Naidu
Published: 01 March 2017
... situations. neuroleptics antihistamines analeptics corticosteroids muscle relaxants antispasmodics NMDA antagonists sympatholytic drugs adjuvants Antipsychotics Betamethasone Celestone Buprenorphine Caffeine Carisoprodol Chlorzoxazone Dexamethasone Decadron Doxapram Gabapentin Hydromorphone...
Chapter
Effects of N-Methyl-d-Aspartate Receptor Antagonists on Vestibular Compensation in the Guinea Pig: In Vivo and In Vitro Studies
Get access
Paul F. Smith and Cynthia L. Darlington
Published: 16 April 1992
...This study investigates the contribution of NMDA receptors to vestibular compensation for UL in the guinea pig using the NMDA receptor/channel antagonists. Three experimental approaches were taken to examine the effect of NMDA antagonists on vestibular compensation. The results imply that NMDA...
Chapter
Competitive NMDA antagonists as drugs
Get access
B. S. MELDRUM and A. G. CHAPMAN
Published: 09 February 1995
...The potential clinical applications of N -methyl-d -aspartate (NMDA) antagonists were initially defined on the basis of animal models. Epilepsy was the first target syndrome identified and remains an important potential therapeutic area. Today stroke and traumatic injury...
Chapter
Targets for Neuroprotection in Ischemic Stroke
Get access
Ryan J. Felling
Published: 01 August 2016
.... neuroprotection glutamate NMDA antagonists antioxidants recombinant tissue plasminogen activator (rTPA) magnesium nitric oxide synthase inhibitors superoxide dismutase therapeutic hypothermia Antioxidants CuZn superoxide dismutase SOD1 for stroke neuroprotection Excitotoxic cascade stroke Glutamate...
Chapter
Complex Spine
Get access
Christopher Sobey
Published: 01 April 2019
... central sensitization plays an essential role throughout the perioperative period and should be considered when planning tailored analgesic regimens. The chapter also details how NMDA antagonists such as ketamine can be used in the postoperative setting to reduce pain intensity and decrease opioid use...
Advertisement
Advertisement